Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More
Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More
ABBOTT INDIA | STERLING BIOTECH | ABBOTT INDIA/ STERLING BIOTECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 47.0 | -0.4 | - | View Chart |
P/BV | x | 15.4 | 0.0 | 107,733.0% | View Chart |
Dividend Yield | % | 0.4 | 0.0 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ABBOTT INDIA Mar-19 |
STERLING BIOTECH Dec-13 |
ABBOTT INDIA/ STERLING BIOTECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 8,834 | 11 | 84,134.3% | |
Low | Rs | 5,458 | 3 | 160,514.7% | |
Sales per share (Unadj.) | Rs | 1,731.1 | 26.8 | 6,457.8% | |
Earnings per share (Unadj.) | Rs | 211.9 | -15.0 | -1,416.9% | |
Cash flow per share (Unadj.) | Rs | 219.9 | -5.5 | -4,025.1% | |
Dividends per share (Unadj.) | Rs | 65.00 | 0 | - | |
Dividend yield (eoy) | % | 0.9 | 0 | - | |
Book value per share (Unadj.) | Rs | 945.2 | 54.9 | 1,722.3% | |
Shares outstanding (eoy) | m | 21.25 | 267.87 | 7.9% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 4.1 | 0.3 | 1,592.2% | |
Avg P/E ratio | x | 33.7 | -0.5 | -7,256.6% | |
P/CF ratio (eoy) | x | 32.5 | -1.3 | -2,554.4% | |
Price / Book Value ratio | x | 7.6 | 0.1 | 5,969.9% | |
Dividend payout | % | 30.7 | 0 | - | |
Avg Mkt Cap | Rs m | 151,848 | 1,862 | 8,156.4% | |
No. of employees | `000 | 3.5 | 1.4 | 257.4% | |
Total wages/salary | Rs m | 4,356 | 547 | 796.6% | |
Avg. sales/employee | Rs Th | 10,555.5 | 5,303.3 | 199.0% | |
Avg. wages/employee | Rs Th | 1,249.9 | 403.8 | 309.5% | |
Avg. net profit/employee | Rs Th | 1,292.2 | -2,959.0 | -43.7% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 36,786 | 7,181 | 512.3% | |
Other income | Rs m | 1,133 | 43 | 2,659.4% | |
Total revenues | Rs m | 37,919 | 7,223 | 525.0% | |
Gross profit | Rs m | 6,047 | 947 | 638.6% | |
Depreciation | Rs m | 169 | 2,543 | 6.7% | |
Interest | Rs m | 23 | 4,377 | 0.5% | |
Profit before tax | Rs m | 6,989 | -5,931 | -117.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2,485 | -1,924 | -129.1% | |
Profit after tax | Rs m | 4,503 | -4,007 | -112.4% | |
Gross profit margin | % | 16.4 | 13.2 | 124.7% | |
Effective tax rate | % | 35.6 | 32.4 | 109.6% | |
Net profit margin | % | 12.2 | -55.8 | -21.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 27,610 | 14,335 | 192.6% | |
Current liabilities | Rs m | 8,569 | 49,809 | 17.2% | |
Net working cap to sales | % | 51.8 | -494.0 | -10.5% | |
Current ratio | x | 3.2 | 0.3 | 1,119.6% | |
Inventory Days | Days | 60 | 403 | 14.9% | |
Debtors Days | Days | 27 | 171 | 16.1% | |
Net fixed assets | Rs m | 1,057 | 55,432 | 1.9% | |
Share capital | Rs m | 213 | 268 | 79.3% | |
"Free" reserves | Rs m | 19,873 | 13,935 | 142.6% | |
Net worth | Rs m | 20,086 | 14,701 | 136.6% | |
Long term debt | Rs m | 0 | 9,478 | 0.0% | |
Total assets | Rs m | 29,409 | 73,988 | 39.7% | |
Interest coverage | x | 311.6 | -0.4 | -87,784.3% | |
Debt to equity ratio | x | 0 | 0.6 | 0.0% | |
Sales to assets ratio | x | 1.3 | 0.1 | 1,288.8% | |
Return on assets | % | 15.4 | 0.5 | 3,072.4% | |
Return on equity | % | 22.4 | -27.3 | -82.3% | |
Return on capital | % | 34.9 | -6.4 | -543.2% | |
Exports to sales | % | 0 | 25.9 | 0.0% | |
Imports to sales | % | 0 | 0.2 | 0.0% | |
Exports (fob) | Rs m | NA | 1,860 | 0.0% | |
Imports (cif) | Rs m | NA | 12 | 0.0% | |
Fx inflow | Rs m | 369 | 1,860 | 19.8% | |
Fx outflow | Rs m | 4,918 | 25 | 19,760.6% | |
Net fx | Rs m | -4,549 | 1,835 | -247.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 4,991 | 1,719 | 290.4% | |
From Investments | Rs m | -2,570 | -3,148 | 81.6% | |
From Financial Activity | Rs m | -1,428 | 1,426 | -100.1% | |
Net Cashflow | Rs m | 993 | -3 | -29,214.7% |
Indian Promoters | % | 0.0 | 33.9 | - | |
Foreign collaborators | % | 75.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 7.9 | 0.0 | - | |
FIIs | % | 0.1 | 9.9 | 1.0% | |
ADR/GDR | % | 0.0 | 16.9 | - | |
Free float | % | 17.1 | 39.3 | 43.5% | |
Shareholders | 18,270 | 21,482 | 85.0% | ||
Pledged promoter(s) holding | % | 0.0 | 55.9 | - |
Compare ABBOTT INDIA With: ALEMBIC PHARMA STRIDES PHARMA SCIENCE TTK HEALTHCARE ASTRAZENECA PHARMA BIOCON
Compare ABBOTT INDIA With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US) TEVA PHARMA (Israel)
After opening the day on a strong note, Indian share markets witnessed a sharp sell-off during closing hours today and ended lower.
For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.
For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.
For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.
For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.
For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.
More Views on NewsThe smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.
The charts are telling the bulls to be cautious.
Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
Our ace stock picker is ready to capitalise on a big growth opportunity.
More